HHMI
PH icon

Howard Hughes Medical Institute’s Parker-Hannifin PH Stock Holding History

Howard Hughes Medical Institute’s Portfolio PH Stock Details PH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27
Closed -$23.7K – 369
2025
Q4 		$23.7K Hold
27
– – 0.01% 98
2025
Q3 		$20.5K Hold
27
– – 0.01% 114
2025
Q2 		$18.9K Buy
+27
New +$17.1K 0.01% 116
2017
Q3 		– Sell
-568
Closed -$91K – 98
2017
Q2 		$91K Buy
+568
New +$90K 0.02% 141

Other funds holding PH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Howard Hughes Medical Institute's PH Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Parker-Hannifin (PH) in Q1 2026, closing a stake of 27 shares — an estimated $23.7K sold.

Howard Hughes Medical Institute first reported a position in PH in Q2 2017 and held it in 4 quarters. The position peaked at $91K in Q2 2017. 1,924 funds tracked by Wall St. Rank hold PH as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Parker-Hannifin position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 27 Parker-Hannifin shares in Q1 2026, an estimated $23.7K.
  • Howard Hughes Medical Institute first reported a position in Parker-Hannifin in Q2 2017 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Parker-Hannifin position peaked at $91K in Q2 2017.
  • 1,924 funds tracked by Wall St. Rank held Parker-Hannifin as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.